We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Says PDUFA Proposal Makes Drug Reviews More Thorough, Transparent
FDA Says PDUFA Proposal Makes Drug Reviews More Thorough, Transparent
February 23, 2007
Recommendations in the latest installment of the Prescription Drug User Fee Act (PDUFA) seek to bulk up the premarket drug approval process, stabilize financing and expedite drug development, FDA officials said at a recent public hearing.